stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Granules India Limited

India 路 NSE:聽GRANULES.NS 路 Market cap: 路 P/E: 路 P/S:

Granules India makes the active ingredients and finished pills that other drug companies sell under their own brands.

Granules India is a drugmaker that mostly works behind the scenes. It produces three things: active pharmaceutical ingredients (the actual chemical that makes a medicine work), pharmaceutical formulation intermediates (the partly finished powder or granules that get pressed into tablets), and finished dosages (the ready-to-swallow tablets and capsules). Its customers are other pharmaceutical companies, in India and abroad, who put their own brand names on the pills and sell them to pharmacies and hospitals.

The way to picture it is a contract kitchen: Granules cooks the meal, and somebody else puts it on the menu under their name. The company's big advantage is that it makes the underlying chemical itself rather than buying it in. That vertical integration lets it control costs and quality from raw material to finished tablet. Many of its customers are in the United States and Europe, so it operates under the tough quality inspections those markets require, which is both a barrier for rivals and a constant source of risk for Granules. The business is tied to a handful of common, high-volume medicines, especially pain relievers like paracetamol, where the money is made on scale rather than on high prices. Serving regulated Western markets means the company is exposed to price pressure from generic competition and to the constant threat of regulatory action at its plants. A single failed inspection can freeze shipments to a major market overnight, so plant compliance is effectively the company's lifeline.


Granules began in the 1980s as a small maker of active ingredients and grew by pushing downstream into intermediates and finished pills, which carry better margins. Its main listed rivals in the Indian generics space include Divi's Laboratories and Aurobindo Pharma, though Granules competes more on being a dependable supplier than on blockbuster drugs. The company also has a consumer health arm selling over-the-counter products in India, a smaller bet on selling directly to everyday shoppers.

Saved answer 路 last researched 16 Nov 2026